연구성과로 돌아가기
2023 연구자 정보 (558 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Chong, So Young (Chong, SY) |
CHA Univ, CHA Bundang Med Ctr, Seongnam, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | |||
|
Do, Young Rok (Do, YR) |
Keimyung Univ, Dongsan Hosp, Daegu, South Korea Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea Keimyung Univ, Dept Internal Med, Dongsan Med Ctr, Daegu, South Korea Keimyung Univ, Dongsan Med Ctr, Dept Hematooncol, Daegu, South Korea Keimyung Univ, Dept Hematol Oncol, Sch Med, Daegu, South Korea Keimyung Univ, Keimyung Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea Keimyung Univ, Dongsan Med Ctr, Dept Hematol & Oncol, Sch Med, Daegu, South Korea Keimyung Univ, Dept Hematooncol, Dongsan Med Ctr, Daegu, South Korea Dongsan Med Ctr, Daegu, South Korea |
|
|
[JCR상위 17.7] ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMAS [JCR상위 17.7] EFFECT OF AUTOLOGOUS STEM CELL TRANSPLANTATION ON SUBSEQUENT TREATMENT AFTER FIRST RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA [JCR상위 1.5] Multicenter, Prospective Study to Investigate the Efficacy and Safety of IntravenousImmunoglobulin Therapy in Elderly Patients with Diffuse Large B Cell Lymphoma Treated with R-Mini-CHOP [JCR상위 11.2] Lupenone attenuates thapsigargin-induced endoplasmic reticulum stress and apoptosis in pancreatic beta cells possibly through inhibition of protein tyrosine kinase 2 activity [JCR상위 35.6] Clinical outcomes of older patients aged 80 and over with newly diagnosed multiple myeloma [JCR상위 28.1] Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma (vol 38, pg 238, 2023) [JCR상위 28.1] Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma [JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) [JCR상위 28.1] Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 49.0] A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 35.6] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE ESCI |
1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY HEMATOLOGY;ONCOLOGY MEDICINE, GENERAL & INTERNAL ONCOLOGY |
dksong@kmu.ac.kr; jhmoon@knu.ac.kr; shglory@hanmail.net;HEMAKIM@yuhs.ac; kstwoh@skku.edu;drydh1685@hotmail.com; |
||
|
Im, Ho Joon (Im, HJ) |
Univ Ulsan, Asan Med Ctr, Childrens Hosp, Coll Med, Seoul, South Korea Univ Ulsan, Asan Med Ctr Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol,Coll Med, Seoul, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY [JCR상위 28.4] Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
choihs1786@snubh.org;kanghj@snu.ac.kr; | ||
|
Jang, Jun-Ho (Jang, JH) |
Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Catholic Univ Korea, Seoul, South Korea Kyungpook Natl Univ Hosp, Daegu, South Korea Soon Chun Hyang Univ Hosp, Seoul, South Korea Dong A Univ, Coll Med, Busan, South Korea Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada |
|
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
f0115@jnu.ac.kr; | ||
|
Ju, Hee Young (Ju, HY) |
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea |
|
|
[JCR상위 17.7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A STUDY OF THE KOREAN BLOOD AND MARROW TRANSPLANTATION REGISTRY | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | |||
|
Jung, Chul Won (Jung, CW) |
Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Catholic Univ Korea, Seoul, South Korea Kyungpook Natl Univ Hosp, Daegu, South Korea Soon Chun Hyang Univ Hosp, Seoul, South Korea Dong A Univ, Coll Med, Busan, South Korea Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea |
|
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY |
f0115@jnu.ac.kr; | ||
|
Jung, Sung-Hoon (Jung, SH) |
Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea Chonnam Natl Univ, Med Sch, Hwasun, Jeollanamdo, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Sch Med, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Sch Med, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, South Korea Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Sch Med, Dept Hematol Oncol, Hwasun, South Korea Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea Chonnam Natl Univ, Med Sch, Hwasun, South Korea |
E-8074-2011 Hyun-Jung, Kim |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia [JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) [JCR상위 35.6] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 28.4] Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study [JCR상위 35.6] Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY HEMATOLOGY;ONCOLOGY HEMATOLOGY |
f0115@jnu.ac.kr; shglory@hanmail.net;HEMAKIM@yuhs.ac; ckmin@catholic.ac.kr;hseom@ncc.re.kr; |
||
|
Kang, Shi Hyun (Kang, SH) |
Natl Ctr Mental Hlth, Dept Social Psychiat & Rehabil, Seoul, South Korea |
|
|
[JCR상위 17.7] Predictors of full recovery in patients with early stage schizophrenia spectrum disorders | SCIE;SSCI | 17.7 | PSYCHIATRY | chungyc@jbnu.ac.kr; | ||
|
Kim, Byeunggon (Kim, B) |
Kyungpook Natl Univ, Dept Chem Engn, Daegu 41566, South Korea |
LXW-3860-2024 Kim, Byeunggon |
0000-0001-5668-5086 Kim, Byeunggon |
[JCR상위 17.7] Microfluidic formation of surface nanodroplets using green deep eutectic solvents for liquid-liquid nanoextraction and controlled precipitation [JCR상위 19.3] CNT-functionalized electrospun fiber mat for a stretchable moisture-driven power generator |
SCIE | 17.7 |
CHEMISTRY, PHYSICAL MATERIALS SCIENCE, MULTIDISCIPLINARY;PHYSICS, APPLIED |
jb.you@knu.ac.kr; jb.you@knu.ac.kr;shjeong@knu.ac.kr; |
||
|
Kim, Da Jung (Kim, DJ) |
Kosin Univ, Busan, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | |||
|
Kim, Dennis Dong Hwan (Kim, DDH) |
Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada |
AAH-8499-2019 Kim, Dennis |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
f0115@jnu.ac.kr; | ||
|
Kim, Do-Young (Kim, DY) |
Pusan Natl Univ Hosp, Busan, South Korea |
|
|
[JCR상위 17.7] NATION-WIDE RETROSPECTIVE ANALYSIS OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: A STUDY FROM KOREAN MULTIPLE MYELOMA WORKING PARTY (KMM1913) | SCIE | 17.7 | HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION | |||
|
Kim, Eui Tae (Kim, ET) |
Seoul Natl Univ, Dept Psychiat, Bundang Hosp, Seongnam, South Korea |
|
|
[JCR상위 17.7] Predictors of full recovery in patients with early stage schizophrenia spectrum disorders | SCIE;SSCI | 17.7 | PSYCHIATRY | chungyc@jbnu.ac.kr; | ||
|
Kim, Hee Je (Kim, HJ) |
Catholic Univ Korea, Seoul St Marys Hosp, Canc Res Inst, Coll Med,Dept Hematol, Seoul, South Korea |
O-3501-2019 Kim, Hee-Je |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
f0115@jnu.ac.kr; | ||
|
Kim, Hyeoung-Joon (Kim, HJ) |
제1저자 |
Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Hwasun Hosp, Hwasun, South Korea |
IAP-6721-2023 Kim, Chang Gon |
|
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1 [JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia |
SCIE | 17.7 |
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION ONCOLOGY |
f0115@jnu.ac.kr; |
페이지 이동: